Peri-op TOC
10. RHEUMATOLOGIC CONCERNS
RHEUMATOID
ARTHRITIS
SPECIFIC CONCERNS IN RA PATIENTS:
-
Cervical spine disease-particularly C1-C2 subluxation, which is a major concern
for endotracheal anesthesia. Cervical spine instability may be asymptomatic
but usually occurs in patients with longstanding, deforming disease. If not
done previously, C-spine flexion/ extension films are recommended on patients
with signs or symptoms referable to the cervical spine and on patients with
erosive disease and joint deformities. Anesthesia must be made aware of any
cervical spine involvement.
-
Cricoarytenoid arthritis-another major concern for endotracheal anesthesia.
Cricoarytenoid joint involvement may cause difficulty with intubation and,
because of trauma related to the ET tube, may also lead to stridor and airway
obstruction after extubation. If the patient has any history or symptoms
of laryngeal involvement, anesthesia must be made aware. (ENT consultation
may also be appropriate.) Fiberoptic bronchoscope should be available in
the OR when intubating RA patients in whom possible underlying
cricoarytenoid disease is a concern.
-
TMJ arthritis-easy to detect on exam; decreases the oral aperture for intubation.
-
Pulmonary disease-common in RA patients. Pleural effusions and pulmonary
nodules due to RA are typically not of significance for surgery; however,
pulmonary fibrosis is more of a concern, particularly if hypoxia and/or dyspnea
is present. Preoperative CXR is warranted if not done previously.
-
Cardiac disease-cardiac manifestations of RA are not common and include
pericardial effusion, conduction disturbances, AV blocks, regurgitant valve
lesions, and cardiomyopathy.
-
Infection-overall risk is increased in RA patients, even those who are not
receiving steroids or immuno-suppressant agents.
-
Stress dose steroids-recommended for patients on steroid therapy within the
past one year.
-
Immunosuppressant agents (such as Methotrexate and Imuran)-should be held
during the postoperative recovery period; hold preoperatively as well if
time allows.
-
TNF inhibitors (such as Enbrel or Remicade, or Humira)-may significantly increase infection
risk and should be held during the postoperative recovery period; hold
preoperatively as well if time allows. A heightened awareness for perioperative
infection is certainly warranted in patients taking these medications.
PERIOPERATIVE POCKET MANUAL
2005 (Contents)
SYSTEMIC LUPUS
ERYTHEMATOSUS
*SLE is a multisystem disorder. Surgical risk associated with the disease
is related to specific organ involvement, the severity of involvement, and
the activity of the disease. There is also a belief that the stress of surgery
may trigger a lupus flare (although this has not been formally studied).
SPECIFIC CONCERNS IN LUPUS PATIENTS:
-
Renal disease-varies in degree from asymptomatic to complete renal failure
with associated hypertension and edema.
-
Cardiopulmonary involvement-pericarditis, pleuritis, pneumonitis are possible
manifestations.
-
Infection-overall risk is increased in lupus patients, even those who are
not receiving steroids or immunosuppressant agents.
-
Hematologic abnormalities-leukopenia, anemia, thrombocytopenia can be chronic
findings but may worsen with active disease or acute illness.
-
Lupus anticoagulant-associated with thrombosis (not bleeding) and a prolonged
PTT. This does not interfere with surgery itself, but postoperatively leads
to a higher risk of venous or arterial thrombosis.
-
Abdominal pain-may be related to peritonitis, pancreatitis, or mesenteric
ischemia due to lupus.
-
Neurologic manifestations-psychiatric disturbances are the most common; strokes
and seizures are also possible but much less common.
-
Stress dose steroids-recommended for patients on steroid therapy within the
past one year.
-
Immunosuppressant agents (such as Imuran or Cytoxan)-should be held during
the postoperative recovery period; hold preoperatively as well if time allows.
-
Disease activity-clinically active disease is managed acutely with high dose
steroids.
PERIOPERATIVE POCKET MANUAL
2005 (Contents)